retatrutide fda status (LY3437943) — Dosing, Side Effects, & Research | PeptIQ Retatrutide for Weight Loss: TRIUMPH-1

This carefully calibrated receptor selectivity profile contributes to the favorable side effect profile observed in clinical studies, where gastrointestinal adverse events were predominantly mild and occurred mainly during dose escalation phases

Women experience slightly higher nausea rates (31% vs 24%) but similar overall tolerability

The right water keeps them stable for weeks

The Importance of Iron While Taking GLP-1 Inhibitors When taking GLP-1 inhibitors, maintaining adequate iron levels is essential for healthy hair growth

About 3% of participants discontinued due to side effects

Always follow your providers dosing instructions, in part to minimize or avoid side effects